BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 36544369)

  • 21. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
    Cotroneo AM; Castagna A; Putignano S; Lacava R; Fantò F; Monteleone F; Rocca F; Malara A; Gareri P
    Clin Interv Aging; 2013; 8():131-7. PubMed ID: 23403474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective properties of citicoline: facts, doubts and unresolved issues.
    Grieb P
    CNS Drugs; 2014 Mar; 28(3):185-93. PubMed ID: 24504829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of citicoline on acute ischemic stroke: a review.
    Overgaard K
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1764-9. PubMed ID: 24739589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischaemia.
    Grieb P; Gadamski R; Wojda R; Janisz M
    Folia Neuropathol; 2001; 39(3):141-5. PubMed ID: 11770124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection and recovery: recent data at the bench on citicoline.
    Hurtado O; Lizasoain I; Moro MÁ
    Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How effective is citicoline for acute ischaemic stroke?
    Hankey GJ
    Lancet; 2012 Jul; 380(9839):318-20. PubMed ID: 22691568
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
    Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
    Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.
    Hurtado O; Hernández-Jiménez M; Zarruk JG; Cuartero MI; Ballesteros I; Camarero G; Moraga A; Pradillo JM; Moro MA; Lizasoain I
    J Neurochem; 2013 Sep; 126(6):819-26. PubMed ID: 23600725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The assessment of the efficacy of citicoline in the early and recovery stages of stroke].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):93-97. PubMed ID: 28635796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Citicoline in Neurological Disorders: A Systematic Review.
    Jasielski P; Piędel F; Piwek M; Rocka A; Petit V; Rejdak K
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citicoline, use in cognitive decline: vascular and degenerative.
    García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
    J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The current state of citicholine in cerebral ischemia].
    Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
    Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical treatment of amblyopia: present state and perspectives.
    Campos EC; Fresina M
    Strabismus; 2006 Jun; 14(2):71-3. PubMed ID: 16760111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
    Bonvicini M; Travaglini S; Lelli D; Antonelli Incalzi R; Pedone C
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial.
    Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio AM; Diaz-Arrastia R; Okonkwo DO
    World Neurosurg; 2019 May; 125():e909-e915. PubMed ID: 30763755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology].
    Mashin VV; Belova LA; Bakhtogarimov IR; Bergelson TM; Sharafutdinova RR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):39-43. PubMed ID: 28884715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.